Sage Journals: Discover world-class research

Open access

Research article

First published 2025-6

Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma

Fumou Sun, Yan Cheng, Catherine Ma [...]

Cancer Biomarkers

Retricted access

Research article

First published 2018-2-9

Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS)

G. Caimi, E. Hopps, M. Carlisi [...]

Clinical Hemorheology and Microcirculation

Retricted access

Research article

First published 1998-5

Biology of the Transition of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma

John A. Lust, Kathleen A. Donovan

Cancer Control

Retricted access

Research article

First published 1985-12

T-cell Subsets Defined by Monoclonal Antibodies in Monoclonal Gammopathy of Undetermined Significance (Mgus)

Luigi Cavanna, Michele Di Stasi, Fabio Fornari [...]

Tumori Journal

Open access

Case report

First published 2024

Regression of Intermediate-High Risk Monoclonal Gammopathy of Undetermined Significance (MGUS) With Long-term Use of Curcumin: A Case Report

Terry Golombick, Rajeev Ramakrishna, Arumugam Manoharan

Integrative Cancer Therapies

Free access

Research article

First published 2016-9

Plasma Thrombin Generation and Sensitivity to Activated Protein C Among Patients With Myeloma and Monoclonal Gammopathy of Undetermined Significance

Maeve P. Crowley, Barry Kevane, Susan I. O’Shea [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2016-6

Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance,Smoldering Multiple Myeloma,or Stage 0/1 Chronic Lymphocytic Leukemia)

Terry Golombick, Terrence H. Diamond, Arumugam Manoharan [...]

Integrative Cancer Therapies

Retricted access

Case report

First published 2022-3

AKT answer relating to management of monoclonal gammopathy of undetermined significance (MGUS)

InnovAiT: Education and inspiration for general practice

Retricted access

Case report

First published 2022-3

AKT question relating to management of monoclonal gammopathy of undetermined significance (MGUS)

Yasser Abdel Kerim

InnovAiT: Education and inspiration for general practice

Open access

Brief report

First published 2022-09

Differences in Hospital,Emergency Room and Outpatient Visits Among Adults With and Without Monoclonal Gammopathy of Undetermined Significance

Maira A. Castañeda-Avila, Kate L. Lapane, Sharina D. Person [...]

Cancer Control

Search results